Treatment of Myelofibrosis—Where Are We Now? Interview With Dr. Ronald Hoffman

OncologySTAT Editorial Team. 2011 Jun 22, L Scott Zoeller

Ronald Hoffman, MD, is Professor of Medicine, Hematology, and Medical Oncology and Professor of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, NY. OncologySTAT: Dr. Hoffman, would you talk about some of the challenges associated with treatment for patients with myelofibrosis? What options are currently available to alleviate constitutional symptoms and anemia?Dr. Hoffman: Myelofibrosis is one of the Philadelphia chromosome–negative myeloproliferative neoplasms, which include polycythemia...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Section Editor

Dr. Howard Scher is Section Editor of When the Smoke Clears.

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration